Back to resultsOncology Episode Payment Model in Hawaii
Primary Purpose
Breast Cancer, Colon Cancer, Lung Cancer
Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Cancer Episode Payment Model (CEM)
Sponsored by
About this trial
This is an interventional health services research trial for Breast Cancer
Eligibility Criteria
Inclusion Criteria:
- Any oncologist who practices with Hawaii Oncology and is a participating provider.
Exclusion Criteria:
- Any provider who does not practice with Hawaii Oncology.
Sites / Locations
- Hawaii Oncology
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Cancer Episode Payment Model
Fee for Service
Arm Description
Oncologists in this arm will be paid for each member's episode of care. The episode of care is 6 months in duration. Oncologists will have the opportunity to receive performance-based payments based upon a set of 6 quality metrics.
Oncologists in this arm will not receive the intervention and will continue to be paid through fee-for-service.
Outcomes
Primary Outcome Measures
Composite quality score
Quality metrics included in the oncology model will be compared across the two arms.
Episode cost
Total spending of oncology patients in the episode will be compared across the two arms.
Utilization of acute and specialty care
Total utilization of acute and specialty care of oncology patients in the episode will be compared across the two arms
Secondary Outcome Measures
Quality of care at end of life
Quality measures evaluating use of acute care and palliative care services at the end of life will be compared across the two arms
Survival
All cause mortality will be compared across the two arms
Full Information
NCT ID
NCT03523546
First Posted
April 19, 2018
Last Updated
February 9, 2023
Sponsor
University of Pennsylvania
Collaborators
Hawaii Medical Service Association
1. Study Identification
Unique Protocol Identification Number
NCT03523546
Brief Title
Oncology Episode Payment Model in Hawaii
Official Title
Oncology Episode Payment Model in Hawaii
Study Type
Interventional
2. Study Status
Record Verification Date
February 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
August 1, 2018 (Actual)
Primary Completion Date
January 1, 2024 (Anticipated)
Study Completion Date
January 31, 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Pennsylvania
Collaborators
Hawaii Medical Service Association
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The HMSA Cancer Episode Payment Model (CEM) is a payment model designed to test the effects of better care coordination on health outcomes and costs of care for Hawaii Medical Services Association (HMSA) members with cancer who receive chemotherapy.
Detailed Description
The CEM is designed to improve community health, to improve care coordination, quality, and appropriateness of care, to improve patient experience, and to implement a value-based incentive structure that appropriately rewards oncologists for cost-savings and sustained of improved quality of care.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Cancer, Colon Cancer, Lung Cancer
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
7 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Cancer Episode Payment Model
Arm Type
Experimental
Arm Description
Oncologists in this arm will be paid for each member's episode of care. The episode of care is 6 months in duration. Oncologists will have the opportunity to receive performance-based payments based upon a set of 6 quality metrics.
Arm Title
Fee for Service
Arm Type
No Intervention
Arm Description
Oncologists in this arm will not receive the intervention and will continue to be paid through fee-for-service.
Intervention Type
Other
Intervention Name(s)
Cancer Episode Payment Model (CEM)
Intervention Description
Oncologists will be paid for an episode of care with the opportunity to receive a value based payment based on 6 quality metrics.
Primary Outcome Measure Information:
Title
Composite quality score
Description
Quality metrics included in the oncology model will be compared across the two arms.
Time Frame
1 year
Title
Episode cost
Description
Total spending of oncology patients in the episode will be compared across the two arms.
Time Frame
6 months
Title
Utilization of acute and specialty care
Description
Total utilization of acute and specialty care of oncology patients in the episode will be compared across the two arms
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Quality of care at end of life
Description
Quality measures evaluating use of acute care and palliative care services at the end of life will be compared across the two arms
Time Frame
6 months
Title
Survival
Description
All cause mortality will be compared across the two arms
Time Frame
one year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Any oncologist who practices with Hawaii Oncology and is a participating provider.
Exclusion Criteria:
Any provider who does not practice with Hawaii Oncology.
Facility Information:
Facility Name
Hawaii Oncology
City
Honolulu
State/Province
Hawaii
ZIP/Postal Code
96701
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Oncology Episode Payment Model in Hawaii
We'll reach out to this number within 24 hrs